Eli Lilly and Company
Eli Lilly and Company Common Stock
About This Listing
Pharmaceutical giant leading in diabetes, oncology, and neuroscience. Maker of blockbuster GLP-1 drugs Mounjaro and Zepbound.
Company Financials
| Annual Revenue | $253,000.00M |
| Net Profit | $2,000.00M |
| Company Valuation | $505,000.00M |
| Market Cap | $151.69M |
Price History
Current Price
$936.34
Available Shares
162,000
Total Shares
162,000
Min Purchase
1
Max Purchase
5,000
0% sold
0 / 162,000
Related Listings
UnitedHealth Group
UnitedHealth Group Common Stock
$277.07
per share
65,513 sold
73,487 available
Johnson & Johnson
Johnson & Johnson Common Stock
$243.61
per share
54,718 sold
20,282 available
Pfizer Inc.
Pfizer Inc. Common Stock
$28.40
per share
45,162 sold
28,838 available